AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2014
Nov 25, 2014
29828_dirs_2014-11-25_6e8cfb80-1167-4cb2-84ff-e2f9445ab2c0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2014-11-21
Reporting Person: Cogan John Francis (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-11-21 | Common Stock | M | 25000 | $14.3375 | Acquired | 67405 | Direct |
| 2014-11-21 | Common Stock | S | 14985 | $100.8557 | Disposed | 52420 | Direct |
| 2014-11-21 | Common Stock | S | 7515 | $101.5532 | Disposed | 44905 | Direct |
| 2014-11-21 | Common Stock | S | 2500 | $102.51 | Disposed | 42405 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-11-21 | Non-Qualified Stock Option (Right to Buy) | $14.3375 | M | 25000 | Disposed | 2016-05-10 | Common Stock (25000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: Options are 100% vested on the date of grant.
F3: Sale prices reported for the transactions reported here range from $100.265 to $101.26. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $101.29 to $102.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.